Long-Term Efficacy and Safety of Cyclosporine in Renal-Transplant Recipients

Abstract

The majority of renal-transplant patients tolerate long-term cyclosporine therapy without evidence of progressive toxic nephropathy. Graft failure is most often due to rejection.